Article Details
Retrieved on: 2025-03-13 05:26:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article covers the growing biopharma landscape in India, highlighting Sun Pharma's acquisition to expand cancer immunotherapy for cutaneous squamous-cell carcinoma and Miltenyi Biotec's and TechInvention's initiatives in gene and RNA vaccine therapies, enhancing India's biotechnology infrastructure.
Article found on: www.bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here